We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Notice for crisantaspase (Jazz Pharmaceuticals ANZ Pty Ltd)
Active ingredients
crisantaspase
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Indication
JZP-458 is used in combination with other chemotherapeutic agents to treat patients with acute lymphoblastic leukaemia (ALL) or lymphoblastic lymphoma (LBL)
Therapeutic area
Haematology